Home NDC 0615-5533 Senna Plus
Product NDC 0615-5533
11-digit product format 006155533
Labeler code 0615
Product ID 0615-5533_e9986c17-4f29-4207-a82d-3f7323012bdc
Type HUMAN OTC DRUG
Nonproprietary name Sennosides and Docusate Sodium
Dosage form TABLET
Route ORAL
Labeler NCS HealthCare of KY, Inc dba Vangard Labs
Application part334
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2011-06-16
Marketing end 0000-00-00
Substance DOCUSATE SODIUM; SENNOSIDES
Active strength 50 mg/1; mg/1
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 45 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0615-5533-31 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0615-5533-39 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0615-5533-31 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0615-5533-39 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0615-5533-31 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0615-5533-39 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0615-5533-31 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0615-5533-39 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0615-5533-31 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0615-5533-39 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0615-5533-31 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0615-5533-39 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0615-5533-31 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0615-5533-39 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0615-5533-31 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0615-5533-39 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0615-5533-31 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0615-5533-39 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0615-5533-31 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0615-5533-39 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0615-5533-31 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0615-5533-39 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0615-5533-31 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0615-5533-39 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 0615-5533-39 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 0615-5533-31 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 0615-5533-39 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 0615-5533-31 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 0615-5533-31 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 0615-5533-39 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded DOCUSATE SODIUM ACTIVE INGREDIENT F05Q2T2JA0 SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 SENNOSIDES ACTIVE INGREDIENT 3FYP5M0IJX SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 DOCUSATE ACTIVE MOIETY M7P27195AG SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 SENNOSIDES ACTIVE MOIETY 3FYP5M0IJX SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS INACTIVE INGREDIENT L11K75P92J SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 FD&C YELLOW NO. 5 INACTIVE INGREDIENT I753WB2F1M SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 MAGNESIUM SILICATE INACTIVE INGREDIENT 9B9691B2N9 SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 MINERAL OIL INACTIVE INGREDIENT T5L8T28FGP SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 SODIUM BENZOATE INACTIVE INGREDIENT OJ245FE5EU SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 STARCH, TAPIOCA INACTIVE INGREDIENT 24SC3U704I SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 TARTARIC ACID INACTIVE INGREDIENT W4888I119H SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 SENNA PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8